Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1998; 80(04): 722-724
DOI: 10.1055/s-0037-1615460
DOI: 10.1055/s-0037-1615460
Letters to the Editor
Tissue Factor and Tissue Factor Pathway Inhibitor in Acute and Chronic Renal Failure
Further Information
Publication History
Received
16 April 1998
Accepted after revision
24 June 1998
Publication Date:
08 December 2017 (online)
-
References
- 1 Broze GJ. Jr. Tissue factor pathway inhibitor. Thromb Haemostas 1995; 74: 90-3.
- 2 Sagripanti A, Barsotti G. Bleeding and thrombosis in chronic uremia. Nephron 1998; 75: 125-39.
- 3 Malyszko J, Malyszko JS, Pawlak D, Pawlak K, Buczko W, Mysliwiec M. Platelet function, hemostasis and serotonin in acute and chronic renal failure. Thromb Res 1996; 83: 351-61.
- 4 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imerson JD, Thompson SG. Haemostatic function and ischemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-7.
- 5 Cella G, Vertolli U, Naso A, Vianello A, Rampin E, Sharai A, Boeri G, Strauss WE. Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis. Thromb Res 1996; 81: 671-7.
- 6 Kario K, Matsuo T, Yamada T, Matsuo M. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis. Thromb Haemostas 1994; 71: 275-9.
- 7 Kario K, Matsuo T, Matsuo M, Koide M, Yamada T, Nakamura S, Sakata T, Kato H, Miyata T. Marked increase of activated factor VII in uremic patients. Thromb Haemostas 1995; 73: 763-7.
- 8 Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S, Kuriyama R, Matsuzawa K, Hasegawa R, Aoki N. Determination of plasma tissue factor antigen and clinical significance. Brit J Haematol 1994; 87: 343-7.
- 9 Fukuda C, Iijima K, Nakamura K. Measuring tissue factor (factor III) activity in plasma. Clin Chem 1989; 35: 1897-900.